Congenital factor V deficiency is a rare genetic bleeding disorder that affects how blood clots. People with congenital factor V deficiency often have easy bruising, frequent nosebleeds, and prolonged bleeding after cuts, dental work, or surgery. Signs usually appear in childhood and the condition is lifelong, but not everyone will have the same severity. Most people with congenital factor V deficiency live a normal lifespan when bleeding is well managed. Treatment often includes clotting support with fresh frozen plasma during bleeds or procedures, and daily care focuses on avoiding unnecessary blood thinners and planning ahead for medical or dental work.
Overview
Congenital factor v deficiencySymptoms
Congenital factor V deficiency often shows as easy bruising, frequent nosebleeds, and prolonged bleeding after cuts, dental work, or surgery. Newborns may have umbilical stump bleeding; children and adults can have heavy periods or mouth bleeding. Severity varies widely.
Outlook and prognosis
Many people with congenital factor V deficiency lead full lives, especially when bleeding risks are managed. Severity varies: some have mild nosebleeds or easy bruising, while others need closer monitoring and treatment during surgery, dental work, or childbirth. With planned care and prompt treatment for bleeds, long‑term outlook is generally good.
Causes and risk factors
Congenital factor V deficiency results from inherited F5 gene changes, usually autosomal recessive. Risk is higher when both parents are carriers, including with consanguinity. Bleeding risk rises with surgery, dental work, trauma, childbirth, and blood‑thinning medicines like NSAIDs.
Genetic influences
Genetics plays a central role in congenital factor V deficiency, which is usually inherited in an autosomal recessive pattern. Variants in the F5 gene reduce factor V activity, affecting clot formation. Family history and genetic testing can clarify inheritance risks and guide care.
Diagnosis
Doctors consider bleeding history and exam, then order clotting tests. Prolonged PT and aPTT that correct on mixing, with low factor V activity, support the diagnosis of Congenital factor V deficiency. Genetic testing of F5 can confirm the genetic diagnosis.
Treatment and drugs
Treatment for congenital factor V deficiency focuses on preventing and controlling bleeding. Care often includes plasma infusions to raise factor V levels, antifibrinolytics for mouth or nose bleeds, and careful planning for surgery, dental work, and pregnancy. Some benefit from thrombosis monitoring and personalized bleeding action plans.
Symptoms
In everyday life, common signs show up as easy bruising, frequent nosebleeds, and bleeding that lasts longer than expected. Early on, this might look like a few extra bruises or nosebleeds that are hard to stop. Early features of Congenital factor V deficiency can also include heavy periods and prolonged bleeding after dental work or surgery. Signs can range from very mild to more pronounced, and they may change over time.
Small bumps can leave larger or more frequent bruises. Bruises may take longer to fade than you’re used to.
Nosebleeds can start without a clear trigger and be hard to stop. Pinching the soft part of the nose helps, but bleeding may last longer than expected.
Gums may bleed with brushing or flossing. After a dental cleaning, oozing can continue for hours.
Periods can be heavier, longer, or include larger clots. Many living with congenital factor V deficiency need to change pads or tampons more often.
How people usually first notice Congenital factor v deficiency?
Many families first notice the first signs of congenital factor V deficiency when a newborn has unusual or prolonged bleeding, such as oozing from heel sticks, the umbilical stump, or after circumcision, or when easy bruising appears with minor bumps. As children grow, nosebleeds that are hard to stop, frequent mouth or gum bleeding (especially with teething or dental care), and prolonged bleeding after small cuts or injections often prompt evaluation; in people who menstruate, heavy periods can be an early clue in adolescence. Doctors often first recognize how congenital factor V deficiency is first noticed through abnormal clotting test results (prolonged PT and aPTT) during workups for these bleeding symptoms, even though platelet counts are normal.
Types of Congenital factor v deficiency
Congenital factor V deficiency has a few recognized clinical variants that differ in severity and bleeding pattern. These variants relate to how much working factor V is present in blood and sometimes in platelets. Symptoms don’t always look the same for everyone. Understanding the main variants can help you and your care team talk through the types of congenital factor V deficiency you might see in families.
Severe (Type I)
Bleeding tends to start early in life and can include nosebleeds, easy bruising, gum bleeding, and heavy periods. Lab tests show very low or undetectable factor V in plasma, and symptoms can be frequent or prolonged.
Moderate deficiency
People often have milder, situational bleeding such as after dental work, injury, or surgery. Factor V levels are reduced but not absent, and day‑to‑day bleeding may be minimal.
Mild deficiency
Many have few symptoms and discover the condition during pre‑op testing or family screening. Bleeding usually appears only with a clear trigger, and factor V levels are near the lower end of normal.
Combined V and VIII
A distinct inherited disorder with low factor V and factor VIII together. Bleeding is generally moderate and may show up with procedures, trauma, or heavy periods.
Platelet storage variant
Plasma factor V may be near normal, but platelet factor V is reduced, leading to mucosal bleeding and easy bruising. Diagnosis can be tricky and often requires specialized testing.
What genetics can tell you about symptoms
Some people with congenital factor V deficiency bruise easily, have frequent nosebleeds, or bleed longer after cuts, dental work, or surgery because the F5 gene change lowers factor V, slowing clot formation. Severe variants can cause bleeding into joints or muscles and heavy menstrual periods.
Causes and risk factors
Congenital factor V deficiency is caused by changes in the F5 gene that you inherit from both parents. In some cases, the gene change is new and not found in either parent. Having a gene change doesn’t mean you’ll definitely develop the condition. Key risk factors for congenital factor V deficiency include a family history, parents who are related by blood, and ancestry from areas where carriers are more common. In congenital factor V deficiency, medicines like aspirin or blood thinners, surgery or dental work, pregnancy, and liver disease do not cause it, but they can increase bleeding problems.
Environmental and biological risk factors
Congenital factor V deficiency is present from birth and mainly arises from internal biology rather than anything you did during pregnancy. Doctors often group risks into internal (biological) and external (environmental). For this condition, external risks are limited, and research has not found consistent links to common exposures. Risk factors also don’t predict the early symptoms of congenital factor V deficiency, which can vary widely from person to person.
To date, no specific prenatal exposures have been clearly linked to congenital factor V deficiency. Studies have not shown radiation, heavy metals, or industrial pollutants to increase the chance of this condition.
Advanced maternal or paternal age is not associated with a higher likelihood of congenital factor V deficiency. Unlike some chromosome-related conditions, age-related effects are not seen here.
Common maternal conditions such as diabetes, high blood pressure, or thyroid disease have not been shown to cause congenital factor V deficiency. These health issues still need routine care to support overall pregnancy health.
Prematurity, delivery method (vaginal or cesarean), or birth stress are not known to influence whether a baby has congenital factor V deficiency. They may affect early bleeding risk in general, but not the presence of this condition itself.
Genetic risk factors
Changes in genes that control how factor V is made or transported sit at the root of this condition. These inherited changes can cause Congenital factor v deficiency, most often through an autosomal recessive pattern where two altered copies are needed. Some families have combined deficiency of factor V and factor VIII due to transport-gene changes. Carrying a genetic change doesn’t guarantee the condition will appear, and severity can differ even within the same family.
F5 gene variants: Pathogenic changes in the F5 gene reduce or stop production of functional factor V. This is the most common genetic cause of inherited factor V shortage. Different variants can lead to mild, moderate, or severe reduction in factor V levels.
Autosomal recessive pattern: The condition typically appears when a child inherits one nonworking copy of the gene from each parent. Each pregnancy of two carriers has a 25% chance of Congenital factor v deficiency. Siblings may have different bleeding severity despite the same genotype.
Parental carrier status: Parents who each carry a single F5 change are usually healthy, though factor V levels may be slightly lower. Family history can prompt evaluation before early symptoms of congenital factor v deficiency appear. Knowing carrier status clarifies risks for future children.
Related parents: When parents are related by blood, the chance they share the same rare variant is higher. This raises the likelihood a child will inherit two altered copies. This pattern is a known feature of recessive conditions.
Compound heterozygosity: Many people have two different F5 variants, one on each gene copy. This can still lead to a clinically significant factor V shortfall. Bleeding severity may vary by the type and location of the variants.
Combined FV-FVIII deficiency: Changes in LMAN1 or MCFD2 disrupt transport of clotting proteins, lowering both factor V and factor VIII. Inheritance is autosomal recessive with a 25% chance for affected children when both parents are carriers. Genetic testing can distinguish this from isolated Congenital factor v deficiency.
Single-copy carriers: People with one altered F5 gene often have little or no bleeding. They still have a 50% chance of passing the variant to each child. In some families, carriers show mildly reduced factor V, which can complicate diagnosis.
Lifestyle risk factors
Congenital factor v deficiency is not caused by lifestyle, but daily habits can change bleeding frequency, severity, and complications. Choices around activity, medications, alcohol, dental care, and menstrual management can meaningfully shift your personal bleeding risk. Understanding how lifestyle affects Congenital factor v deficiency helps you prevent avoidable bleeds and recover faster.
High-impact or contact sports raise injury and internal bleeding risk. Favor noncontact, low-impact activities to maintain fitness with fewer trauma-triggered bleeds.
Low-impact training preserves joint and muscle health without provoking bleeding. Balance and strength work may reduce falls and related soft-tissue bleeds.
These medicines inhibit platelets and can markedly increase nose, gum, and joint bleeding. Prefer acetaminophen for pain and confirm all medicines with your hematology team.
Fish oil, ginkgo, garlic, and high-dose vitamin E can impair clotting and raise bleeding risk. Discuss any supplement in advance so it does not compound your bleeding tendency.
Risk prevention
You can’t prevent being born with congenital factor V deficiency, but you can lower the chance of bleeding and manage day-to-day risks. Most prevention focuses on planning ahead, avoiding triggers that thin the blood, and getting the right care before procedures. Even if you can’t remove all risks, prevention can reduce their impact. A hematology team can help tailor steps to your age, lifestyle, and health needs.
Create a personalized bleeding plan with your hematology team. Review what to do for nosebleeds, cuts, periods, and injuries. Update it after any major bleed.
Tell your doctors and dentist before any surgery, dental work, piercing, or tattoo. You may need plasma infusions beforehand to raise factor V. Plan for extra observation afterward.
Avoid aspirin, ibuprofen, and naproxen because they increase bleeding risk. Many supplements like fish oil, ginkgo, and high-dose garlic can also thin blood. Use acetaminophen for pain unless your doctor advises otherwise.
Favor low-impact activities like walking, swimming, and cycling. Use helmets, mouthguards, and pads to protect from bumps and falls. Skip contact or high-collision sports.
Transmission
Congenital factor V deficiency is not contagious; it can’t be caught or spread through everyday contact, coughing, sex, or breastfeeding. This is how congenital factor V deficiency is inherited: in most families, both parents carry one gene change for factor V but have no symptoms. When two carriers have a child, each pregnancy has a 25% (1 in 4) chance the child will have congenital factor V deficiency, a 50% (1 in 2) chance the child will be a carrier like the parents, and a 25% chance of neither. New gene changes can also happen for the first time in a child, so genetic transmission of congenital factor V deficiency can occur even without a known family history, though this is uncommon.
When to test your genes
Consider genetic testing if you or a close relative had unusual bleeding, easy bruising, or bleeding after surgery or dental work without a clear cause. Testing is also reasonable before planned surgery, childbirth, or starting anticoagulants, and for infants with unexplained bleeding. A hematologist or genetic counselor can guide timing and next steps.
Diagnosis
Bleeding that starts early in life or happens after minor bumps often prompts testing for an inherited clotting problem. Doctors usually begin with your story and simple blood tests, then move to more specific studies if results point that way. The diagnosis of Congenital factor V deficiency is confirmed with specialized clotting tests and may be supported by genetic testing. This stepwise approach helps separate it from more common causes of easy bruising or bleeding.
Your team asks about nosebleeds, gum bleeding, heavy periods, or bleeding after dental work or surgery. They also review family patterns to see if others have had similar bleeding.
The exam looks for easy bruising, small skin bleeds, or signs of recent blood loss. Many people with Congenital factor V deficiency have a normal exam between bleeding episodes.
Basic blood tests often show a longer prothrombin time (PT) and activated partial thromboplastin time (aPTT). Platelet count and thrombin time are usually normal, which helps narrow the cause.
Your plasma is mixed with normal plasma to see if the clotting time corrects. Correction suggests a missing clotting factor like factor V rather than an inhibitor or antibody.
Stages of Congenital factor v deficiency
Congenital factor V deficiency does not have defined progression stages. It’s a lifelong bleeding tendency where symptoms can be quiet for long stretches and then flare with injuries, dental work, or periods, so it doesn’t follow a step-by-step decline; early symptoms of congenital factor V deficiency often include easy bruising, frequent nosebleeds, or heavy menstrual bleeding. Different tests may be suggested to help confirm the diagnosis, such as general clotting screens that show delays and a specific test that measures factor V levels, and your clinician will also ask about personal and family bleeding history. Monitoring usually focuses on symptoms over time and repeat blood tests before surgeries, dental procedures, or during pregnancy.
Outlook and prognosis
For many living with congenital factor V deficiency, day-to-day life depends on how severe the bleeding tendency is. Some people mostly notice easy bruising or nosebleeds; others deal with heavy periods, prolonged bleeding after dental work, or, rarely, bleeding inside joints or the belly. Everyone’s journey looks a little different. Early care can make a real difference, especially when planning surgeries, dental procedures, or pregnancy.
Understanding the prognosis can guide planning and help set expectations. In general, congenital factor V deficiency is considered a lifelong condition, but many people reach a stable routine with prompt treatment during bleeds and careful preventive steps before procedures. Severe bleeding in newborns and infants can be dangerous, but with modern care—access to plasma products, antifibrinolytics, and coordinated emergency plans—childhood survival and long-term health are much better than they were decades ago. Most adults with mild to moderate congenital factor V deficiency have a near-normal life expectancy, particularly when they recognize early symptoms of congenital factor V deficiency and seek care quickly.
Looking at the long-term picture can be helpful. Pregnancy needs close monitoring because delivery and the weeks after carry a higher bleeding risk, but successful pregnancies are common with a plan in place. There’s no proven link to higher blood clots from the deficiency itself, though treatment plans may be adjusted if other clotting risks exist. Talk with your doctor about what your personal outlook might look like, including how your factor levels, bleeding history, and any other health conditions shape your long-term risks and the best prevention strategies for you.
Long-term effects
For many, day-to-day life involves watching for bruising or nosebleeds and planning around heavy periods or procedures. Long-term effects vary widely, and some people have only mild issues between bleeds. While early symptoms of congenital factor V deficiency often show up in childhood, the long-term picture depends on bleed severity and life stage. Serious bleeds are uncommon but can leave lasting effects.
Repeated nosebleeds, gum bleeding, and easy bruising can continue over years. Bleeding may flare with minor bumps, colds, or dental irritation.
Periods can be very heavy and prolonged. This can drain energy and disrupt school, work, or travel.
Ongoing blood loss can lead to iron-deficiency anemia. People may feel tired, short of breath, or lightheaded over time.
Procedures tend to carry a higher bleeding risk with delayed oozing. Recovery can take longer due to blood loss.
How is it to live with Congenital factor v deficiency?
Living with congenital factor V deficiency often means planning around bruising, nosebleeds, or heavy menstrual bleeding, and being cautious with activities that could cause cuts or bumps. Many people work closely with their care team to prepare for dental work, surgeries, and pregnancy, carry medical alert information, and keep treatment plans handy for emergencies. Day to day, this can feel manageable with the right routines—avoiding certain medications like aspirin, using protective gear when appropriate, and checking in quickly if bleeding seems unusual. Family and friends often learn basic first-aid, help watch for signs of bleeding, and support the practical side of care, which can make life safer and less stressful.
Treatment and drugs
Treatment for congenital factor V deficiency focuses on preventing and controlling bleeding, especially during injuries, dental work, or surgery. Because there’s no concentrated factor V product, doctors often use fresh frozen plasma to raise factor V levels before and during bleeding episodes or planned procedures; in mild cases, antifibrinolytic medicines like tranexamic acid can help with nosebleeds or dental bleeding. For women with heavy periods, options can include hormonal therapies or tranexamic acid during menses, and pregnancy care is planned closely to lower bleeding risk at delivery. Supportive care can make a real difference in how you feel day to day. Your doctor may suggest a personalized plan that includes an emergency bleeding strategy, vaccines to reduce infection risk from blood products, and coordination with a hematology center for surgeries or if bleeding becomes frequent.
Non-drug treatment
Living with Congenital factor V deficiency affects daily routines mainly because of easy bruising and bleeding. Non-drug treatments often lay the foundation for safer, more active days by lowering risk and preparing you to act quickly if bleeding starts. Knowing early symptoms of Congenital factor V deficiency—like frequent nosebleeds or gum bleeding—can help you use simple first-aid steps sooner. Care plans vary by age and severity, so your team will tailor these strategies to you.
Use a soft toothbrush, electric razor, and avoid sharp tools when possible. Skip aspirin and most NSAIDs unless a clinician specifically approves them. Keep vaccinations and blood draws with gentle pressure afterward to limit bruising.
For a cut, press firmly with clean gauze for 10–15 minutes without peeking. For a joint or muscle bleed, rest, elevate, and use a cold pack wrapped in cloth for 15–20 minutes at a time. Seek urgent care if bleeding is heavy or doesn’t slow.
Sit up, lean forward, and pinch the soft part of the nose for 10–15 minutes. Avoid tilting your head back. Use a room humidifier and saline spray to keep nasal passages moist.
Brush gently twice daily and floss carefully to reduce gum bleeding. Schedule regular cleanings and tell your dentist about Congenital factor V deficiency before any procedure. Local pressure and topical measures can often control minor dental bleeding.
Your genes may have an impact on how drugs work for you
For people with congenital factor V deficiency, genes can affect how well replacement therapies work and how long factor V stays active in the bloodstream. Genetics may also influence bleeding risk, dosing needs, and rare reactions like inhibitor development.
Pharmacological treatments
Most people with congenital factor V deficiency are treated during bleeds or before procedures with medicines that raise clotting support quickly. There isn’t a manufactured factor V concentrate, so care focuses on plasma, platelets, and medicines that help clots hold together. Doctors adjust treatment plans regularly as needs change, like around dental work, childbirth, or surgery. Below are common medication options for congenital factor V deficiency used in hospitals and clinics.
Plasma replaces the missing factor V directly and is the mainstay during bleeds or before surgery. It’s given through a vein in the hospital or infusion center.
Solvent‑detergent–treated plasma provides factor V with added viral safety steps. It’s used similarly to standard plasma when available.
Platelets carry a helpful pool of factor V that supports clotting, especially for mucosal or surgical bleeding. They’re often added if bleeding continues despite plasma.
This antifibrinolytic helps clots stay in place, useful for nosebleeds, heavy periods, and dental work. It can be taken as pills, liquid, or given by vein.
Genetic influences
Most cases are inherited in a recessive pattern: two non-working copies of the F5 gene are needed for symptoms to develop, and parents are usually healthy carriers. A “carrier” means you hold the gene change but may not show symptoms. The F5 gene helps the body make factor V, a clotting protein; when both copies have harmful changes, factor V levels drop and bleeding problems can appear in Congenital factor V deficiency. Severity can vary even within the same family, because different gene changes and other health factors influence how much factor V is available. Genetic testing can confirm the cause and identify carriers among relatives, which can help with planning for pregnancy, surgery, or dental work. This is different from factor V Leiden, a separate F5 change that raises the risk of blood clots rather than bleeding.
Is Congenital factor v deficiency genetic?
Genetics plays a central role in congenital factor V deficiency, which is usually inherited in an autosomal recessive pattern. Variants in the F5 gene reduce factor V activity, affecting clot formation. Family history and genetic testing can clarify inheritance risks and guide care.
Pharmacogenetics—how genetics influence drug effects
The specific genetic change you were born with can influence how low your factor V level is and how often you need treatment for bleeding. Your care team uses your bleeding history and lab results to set the dose and timing of fresh frozen plasma, and in some situations platelet transfusions, especially around procedures. Doctors can use your genetic information to fine‑tune plans for surgery, dental work, or childbirth, and to guide testing for family members. Because there isn’t a standard factor V concentrate in routine use, most medications used to treat congenital factor V deficiency are blood products, so typical drug–gene metabolism issues don’t apply here. If someone also carries a common clot‑risk variant, such as factor V Leiden or a prothrombin gene change, clinicians may balance replacement and antifibrinolytic therapy more carefully to lower clotting risk. Other health factors—like kidney function, infection, and where the bleeding is—also affect how well plasma or tranexamic acid help, so the treatment plan is individualized.
Interactions with other conditions
Living with congenital factor V deficiency, a rare shortage of a blood‑clotting protein, often means thinking about how other health issues might change your bleeding risk. Doctors call it a “comorbidity” when two conditions occur together. Liver disease can be especially important, since the liver makes factor V; if the liver is inflamed or scarred, bleeding can become harder to control and tests may look more abnormal than usual. Other bleeding conditions—like low platelets or von Willebrand disease—and medicines that thin the blood or affect platelets (for example, warfarin, direct oral anticoagulants, or frequent NSAID use) can add up, making nosebleeds, easy bruising, or heavy periods more likely.
Because liver problems can lower several clotting factors at once, early symptoms of congenital factor V deficiency may be harder to tell apart from bleeding due to liver disease. There’s also a separate inherited condition where factor V and factor VIII are both low; people with that overlap can have more frequent or heavier bleeding during dental work, surgery, or childbirth and usually need closer planning. Infections that trigger widespread clotting and bleeding (such as severe sepsis with DIC) can consume factor V and temporarily worsen bleeding, even in someone who is usually mild. If you live with congenital factor V deficiency and another condition, coordinated care—especially before procedures, during pregnancy, or when starting new medicines—helps keep bleeding under control.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described unusually severe or long‑lasting bleeding after minor injuries, dental work, or childbirth. In some families, several relatives bruised easily or had frequent nosebleeds, while others had no symptoms until a surgery uncovered a bleeding problem. These everyday clues, passed down across generations, hinted that a hidden factor in the blood’s clotting system was missing or reduced.
First described in the medical literature as a distinct clotting disorder in the mid‑20th century, congenital factor V deficiency became clearer once laboratory tests could measure specific clotting steps. Initially understood only through symptoms, later studies showed that people with the condition have very low levels of factor V, a protein that helps blood form stable clots. Doctors also noticed that the disorder can look quite different from one person to another—some live for years with only easy bruising, while others face dangerous bleeding after surgery or childbirth.
As medical science evolved, testing moved from broad clotting times to more targeted assays that pinpoint factor V levels. This shift helped separate congenital factor V deficiency from other bleeding conditions that can look similar, such as disorders involving platelets or other clotting proteins. Family studies then confirmed that, for most, this is an inherited condition present from birth, though symptoms may not show up right away.
With each decade, the picture expanded beyond hospital cases to include people with milder symptoms identified during pre‑operative blood work or family screening. Researchers also reported that carriers—those with one altered copy of the gene—usually have normal or near‑normal clotting but can occasionally show mild features, underscoring the condition’s variability. Reports from different regions highlighted that congenital factor V deficiency appears in all ethnic groups, though it may be more common where relatives are closely related by ancestry or marriage.
In recent decades, knowledge has built on a long tradition of observation. Advances in genetics connected the condition to changes in the F5 gene, which can lower factor V production or function. This genetic insight explained why some families see the condition across generations and why severity can vary even within the same family. While no specific factor V concentrate is widely available, the historical shift from symptom‑based descriptions to precise testing has improved diagnosis and guided safer care using therapies that replace clotting components during bleeds or surgeries.
Looking back helps explain why early symptoms of congenital factor V deficiency were often missed, especially when they were mild or sporadic. Today’s understanding stands on that history, allowing earlier recognition, more tailored planning for procedures, and better support for people living with this rare bleeding disorder.